PT3413868T - Composição oftálmica para utilização no tratamento de distúrbios oculares relacionados com alterações da superfície córneo-conjuntival - Google Patents
Composição oftálmica para utilização no tratamento de distúrbios oculares relacionados com alterações da superfície córneo-conjuntivalInfo
- Publication number
- PT3413868T PT3413868T PT168091726T PT16809172T PT3413868T PT 3413868 T PT3413868 T PT 3413868T PT 168091726 T PT168091726 T PT 168091726T PT 16809172 T PT16809172 T PT 16809172T PT 3413868 T PT3413868 T PT 3413868T
- Authority
- PT
- Portugal
- Prior art keywords
- alterations
- treatment
- ophthalmic composition
- disorders related
- eye disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB2016A000543A ITUB20160543A1 (it) | 2016-02-08 | 2016-02-08 | Composizione oftalmica stabilizzante e reintegrante del film lacrimale per uso nella prevenzione delle infezioni virali |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3413868T true PT3413868T (pt) | 2019-10-10 |
Family
ID=55969252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT168091726T PT3413868T (pt) | 2016-02-08 | 2016-11-08 | Composição oftálmica para utilização no tratamento de distúrbios oculares relacionados com alterações da superfície córneo-conjuntival |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP3413868B1 (pt) |
| CN (1) | CN108697635B (pt) |
| EA (1) | EA035539B9 (pt) |
| ES (2) | ES2747501T3 (pt) |
| IT (1) | ITUB20160543A1 (pt) |
| PT (1) | PT3413868T (pt) |
| WO (2) | WO2017137820A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2604239A (en) * | 2019-07-26 | 2022-08-31 | Pandorum Tech Private Limited | Bioengineered formulation, process for preparing and implementations thereof |
| US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| BR102020023560A8 (pt) * | 2019-11-19 | 2023-02-07 | Johnson & Johnson Consumer Inc | Composições e métodos para tratar os olhos |
| US20210299121A1 (en) * | 2020-03-31 | 2021-09-30 | Somerset Therapeutics Llc | Cetirizine ophthalmic compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006104164A (ja) * | 2004-10-08 | 2006-04-20 | Nippon Origo Kk | 新規抗菌剤組成物 |
| DE102005055275A1 (de) * | 2005-11-17 | 2007-05-24 | Ursapharm Arzneimittel Gmbh & Co. Kg | Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung |
| CN101433519B (zh) * | 2008-12-19 | 2013-01-23 | 沈阳药科大学 | 阿奇霉素滴眼剂及其制备方法 |
| ITRM20110105A1 (it) | 2011-03-03 | 2012-09-04 | Sooft Italia Spa | Composizione ed uso di collirio antiedemigeno a base di acido lattobionico |
| CN104095869A (zh) * | 2014-07-28 | 2014-10-15 | 王卫武 | 一种治疗丘疹性荨麻疹的乳膏及其制备方法 |
-
2016
- 2016-02-08 IT ITUB2016A000543A patent/ITUB20160543A1/it unknown
- 2016-11-08 EA EA201891730A patent/EA035539B9/ru unknown
- 2016-11-08 EP EP16809172.6A patent/EP3413868B1/en active Active
- 2016-11-08 CN CN201680081153.0A patent/CN108697635B/zh active Active
- 2016-11-08 PT PT168091726T patent/PT3413868T/pt unknown
- 2016-11-08 ES ES16809172T patent/ES2747501T3/es active Active
- 2016-11-08 WO PCT/IB2016/056719 patent/WO2017137820A1/en active Application Filing
-
2017
- 2017-02-02 WO PCT/IB2017/050561 patent/WO2017137871A1/en active Application Filing
- 2017-02-02 ES ES17705172T patent/ES2758372T3/es active Active
- 2017-02-02 EP EP17705172.9A patent/EP3413871B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EA035539B1 (ru) | 2020-07-01 |
| CN108697635A (zh) | 2018-10-23 |
| EP3413868A1 (en) | 2018-12-19 |
| EP3413871A1 (en) | 2018-12-19 |
| ITUB20160543A1 (it) | 2017-08-08 |
| CN108697635B (zh) | 2021-07-30 |
| ES2758372T3 (es) | 2020-05-05 |
| WO2017137820A1 (en) | 2017-08-17 |
| EP3413868B1 (en) | 2019-08-14 |
| EA035539B9 (ru) | 2020-08-07 |
| ES2747501T3 (es) | 2020-03-10 |
| EP3413871B1 (en) | 2019-11-06 |
| EA201891730A1 (ru) | 2019-01-31 |
| WO2017137871A1 (en) | 2017-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3777830C0 (en) | OPHTHALMIC COMPOSITION FOR THE TREATMENT OF DRY EYE DISEASE | |
| IL236920B (en) | Ophthalmic compositions and their use for treatment of eye diseases and disorders in animals | |
| IL227412A (en) | Administration of cross-materials to corne by iontophoresis for the treatment of keratoconus and ophthalmic preparations for this purpose | |
| HK1256721A1 (zh) | 用於治療眼部病症的化合物和組合物 | |
| IL273531A (en) | Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases | |
| ZA202002066B (en) | Compositions and methods for the treatment of eye disorders | |
| IL281773A (en) | Eye preparation for the treatment of dry eye disease | |
| PT3413868T (pt) | Composição oftálmica para utilização no tratamento de distúrbios oculares relacionados com alterações da superfície córneo-conjuntival | |
| EP3688021A4 (en) | Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders | |
| IL267229A (en) | Methods of treating ocular disorders | |
| PT3302454T (pt) | Composições para utilização no tratamento da doença de parkinson e distúrbios associados | |
| IL284344A (en) | Pharmaceutical preparations for the eyes and methods for the treatment of diseases of the surface of the eye | |
| GB2541840B (en) | Ophthalmic composition for the treatment of ocular infection | |
| ZA202002075B (en) | Compounds, compositions and methods for treatment of eye disorders and skin diseases | |
| EP3691654A4 (en) | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF EYE SURFACE DISEASES | |
| SG11202012473UA (en) | Ophthalmic compositions and methods for the treatment of eye disorders | |
| MX2019011925A (es) | Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular. | |
| IL280588A (en) | Ophthalmic compositions and methods for treating eye problems and skin diseases | |
| IL282898A (en) | Ophthalmic compounds and methods for treating skin and eye diseases | |
| PT3407879T (pt) | Gabapentina oftálmica para o tratamento de úlceras da córnea | |
| ZA202003944B (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
| EP3802491C0 (en) | PHOTOCHROMIC COMPOUNDS FOR USE IN THE TREATMENT OF EYE DISORDERS | |
| IT201700099156A1 (it) | Composizione oftalmica nanoparticellare per il trattamento di disturbi o patologie oculari | |
| GB201603510D0 (en) | Compositions for use in the treatment of neurological disease | |
| EP3129054A4 (en) | Methods and compositions for the treatment of ocular diseases and disorders |